Clinical Trial Activity
CURRENT CLINICAL TRIAL ACTIVITIES
(official titles and (abbreviated titles))
1. Study of MABp1 in Patients with Advanced Cancers (Advanced Cancers)
2. Study of CA-18C3 in Subjects with Advanced Hematologic Malignancies (Hematology)
3. Open Label, Randomized Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of an Anti-inflammatory Therapeutic Antibody (CV-18C3) in Reducing Restenosis in Patients Undergoing Percutaneous Femoro-popliteal Revascularization (Vascular Disease)
4. Open Label Study of the Safety, Pharmacokinetics, and Efficacy of a True HumanTM Anti-Inflammatory Therapeutic Antibody (RA-18C3) in Subjects with Moderate to Severe Plaque Psoriasis (PSORIASIS)
5. Study of the Safety and Pharmacokinetics of an Anti-Inflammatory Therapeutic Antibody (MABp1) in Patients with Type 2 Diabetes Mellitus (Type 2 diabetes)
